Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 47 min ago
Peer-reviewedCC BY 4.0BMC Public Health

Exploring psychosocial and cultural determinants of delayed help-seeking and treatment adherence in Indonesian tuberculosis (TB) patients

Abstract

Introduction: Indonesia bears one of the highest tuberculosis (TB) burdens globally, yet the psychosocial and cultural determinants of delayed help-seeking and non-adherence remain insufficiently understood. This study explores the lived experiences of TB patients in West Java to illuminate the forces driving these gaps and inform patient-centred care.

Methods: A qualitative descriptive study using reflexive thematic analysis, informed by a social constructivist epistemology and a phenomenological orientation to lived experience, was conducted with nine people with TB (seven female, two male; aged 18–42 years) at the DOTS clinic of RSUD dr. Slamet, a public general hospital in Garut, West Java. Participants were purposively sampled. In-depth semi-structured online interviews were analysed using Braun and Clarke’s six phases, with trustworthiness ensured through member checking, audit trails, and reflexive journaling.

Results: Six themes were developed. Four described the context of the illness experience: the meaning of TB symptoms, in which symptoms were normalised and extrapulmonary symptoms were not recognised as TB; the meaning of living with TB, including identity disruption and stigma extending to participants’ children; emotional experiences, which participants retrospectively described as moving from fear and distress after diagnosis towards hopelessness and, for some, acceptance; and treatment experience within healthcare, marked by fragmented diagnostic pathways and inconsistent communication. Two themes addressed the research question directly. Help-seeking was delayed by anticipated and enacted stigma, which some participants described as aib (disgrace), and by structural barriers such as mandatory digital registration. Adherence was shaped by medication fatigue, fear, distressing clinical communication and family relationships that could either sustain or undermine it, and was supported by patient-generated strategies, notably cautionary witnessing (learning from others who had stopped treatment) and fear of having to restart treatment. Family relationships (six of nine participants) and stigma (five of nine) were the most widely shared subthemes, whereas other subthemes rested on two to four accounts.

Conclusions: In this West Java setting, help-seeking and adherence were shaped less by knowledge of TB than by the social meaning of the illness, family obligation and patients’ own coping strategies. TB programmes could build on these by engaging families as partners in adherence, communicating in ways that explain rather than frighten, reducing the visibility of TB services, and offering patient-generated strategies, such as self-monitoring tools, from the start of treatment.

Clinical trial numbers: Not applicable.

Related

  1. Determinants of Anticipated Video-Supported Treatment Acceptability in Drug-Susceptible Pulmonary Tuberculosis
    J. A. Lama, C. R. Seas, J. Peinado Rodriguez +2
    medRxivPreprintAll rights reservedFull textInfectious diseasemedRxiv
  2. Determinants of willingness to accept Tuberculosis Preventive Treatment (TPT) among close contacts with Tuberculosis Infection (TBI) in Xinjiang, China
    Senlu Wang, Baozhen Peng, Mingzhe Wang +12
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0Infectious diseaseCrossref
  3. Effectiveness of psychosocial counselling on treatment adherence among patients with a new tuberculosis diagnosis in primary care: a study protocol for a cluster-randomised controlled trial
    Zahroh Shaluhiyah, Sri Handayani, Ayun Sriatmi +2
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textInfectious diseaseCrossref
  4. Determinants of infection vulnerability and health system capacity affecting tuberculosis treatment success in low- and middle-income countries: panel data analysis 2001–2023
    Emine Kübra Dindar, Burak Sayar, Osman Şenol
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Epidemiology & public healthFrontiersCrossref
  5. Clinical and laboratory determinants of treatment response and rifampicin resistance among Xpert MTB/RIF-confirmed extrapulmonary tuberculosis patients: A prospective study from Central India
    Gautam Bhagwat, Mala Kanthali, Swati Chauhan +3
    PLOS OnePeer-reviewedCC BYFull textGeneral biochemistryCell biologyPLOSEurope PMCPMC
BibTeX
@article{heriawan2026exploring,
  title = {{Exploring psychosocial and cultural determinants of delayed help-seeking and treatment adherence in Indonesian tuberculosis (TB) patients}},
  author = {Indra Santosa Heriawan and Fitri Ariyanti Abidin and Marijtje Jongsma and Zahrotur Rusyda Hinduan},
  journal = {BMC Public Health},
  year = {2026},
  month = nov,
  doi = {10.1186/s12889-026-30272-5},
  url = {https://link.springer.com/article/10.1186/s12889-026-30272-5},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Exploring psychosocial and cultural determinants of delayed help-seeking and treatment adherence in Indonesian tuberculosis (TB) patients
AU  - Indra Santosa Heriawan
AU  - Fitri Ariyanti Abidin
AU  - Marijtje Jongsma
AU  - Zahrotur Rusyda Hinduan
PY  - 2026
DA  - 2026/11/13
JO  - BMC Public Health
DO  - 10.1186/s12889-026-30272-5
UR  - https://link.springer.com/article/10.1186/s12889-026-30272-5
AB  - Introduction: Indonesia bears one of the highest tuberculosis (TB) burdens globally, yet the psychosocial and cultural determinants of delayed help-seeking and non-adherence remain insufficiently understood. This study explores the lived experiences of TB patients in West Java to illuminate the forces driving these gaps and inform patient-centred care.  Methods: A qualitative descriptive study using reflexive thematic analysis, informed by a social constructivist epistemology and a phenomenological orientation to lived experience, was conducted with nine people with TB (seven female, two male; aged 18–42 years) at the DOTS clinic of RSUD dr. Slamet, a public general hospital in Garut, West Java. Participants were purposively sampled. In-depth semi-structured online interviews were analysed using Braun and Clarke’s six phases, with trustworthiness ensured through member checking, audit trails, and reflexive journaling.  Results: Six themes were developed. Four described the context of the illness experience: the meaning of TB symptoms, in which symptoms were normalised and extrapulmonary symptoms were not recognised as TB; the meaning of living with TB, including identity disruption and stigma extending to participants’ children; emotional experiences, which participants retrospectively described as moving from fear and distress after diagnosis towards hopelessness and, for some, acceptance; and treatment experience within healthcare, marked by fragmented diagnostic pathways and inconsistent communication. Two themes addressed the research question directly. Help-seeking was delayed by anticipated and enacted stigma, which some participants described as aib (disgrace), and by structural barriers such as mandatory digital registration. Adherence was shaped by medication fatigue, fear, distressing clinical communication and family relationships that could either sustain or undermine it, and was supported by patient-generated strategies, notably cautionary witnessing (learning from others who had stopped treatment) and fear of having to restart treatment. Family relationships (six of nine participants) and stigma (five of nine) were the most widely shared subthemes, whereas other subthemes rested on two to four accounts.  Conclusions: In this West Java setting, help-seeking and adherence were shaped less by knowledge of TB than by the social meaning of the illness, family obligation and patients’ own coping strategies. TB programmes could build on these by engaging families as partners in adherence, communicating in ways that explain rather than frighten, reducing the visibility of TB services, and offering patient-generated strategies, such as self-monitoring tools, from the start of treatment.  Clinical trial numbers: Not applicable.
SN  - 1471-2458
ER  -